October 19, 2026 · JAMA internal medicine · DOI: 10.1001/jamainternmed.2026.5163

Cost-Effectiveness of HCV Screening in Emergency Departments Using DETECT Hep C Trial Results.

Listen to this summary

This economic evaluation asks whether HCV screening in U.S. emergency departments is cost-effective, comparing no ED screening, targeted screening, and nontargeted (routine) screening using a simulation model informed by the DETECT Hep C trial. Nontargeted screening yielded the most infections cured (65.89%) at an ICER of about $12,820 per QALY gained, well below the $100,000/QALY threshold, with costs similar across strategies. The authors conclude that routine nontargeted HCV screening in EDs offers good economic value and could support HCV elimination efforts.

Larsan M W Czoty, Sarah Munroe, Emily Stewart, Jason Haukoos, Sarah E Rowan, Emily Hopkins, Richard E Rothman, James W Galbraith, Yu-Hsiang Hsieh, Carolynn Lyle, Stephanie Gravitz, Kevin F Kamis, Douglas A E White, Michael S Lyons, Edward M Gardner, Alia A Al-Tayyib, Allison L Sabel, David L Wyles, Dimitri Baptiste, Benjamin P Linas, Jake R Morgan

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play